UNIVERSITY OF SOUTHERN CALIFORNIA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1880-01-01

Employees: 10K

Market Cap: -

Website: http://startusc.com

Clinical Trials

Ovulation Incidence in Oral Contraceptive Users

Phase 3

Suspended

Conditions: Contraception
Ovulation

Interventions: Drug: Ethinyl Estradiol, Norethindrone acetate, ferrous fumarate
Drug: Norethindrone

First Posted Date: 2017-04-10

Last Posted Date: 2024-12-11

Lead Sponsor: University of Southern California

Target Recruit Count: 58

Registration Number: NCT03106454

Locations: 🇺🇸
Brian T. Nguyen, Los Angeles, California, United States

The Effectiveness of IV/PO Acetaminophen in the Perioperative Period in Reducing Opiate Use After Lumbar Spine Fusion

Phase 4

Terminated

Conditions: Fusion of Spine, Lumbar Region

Interventions: Drug: Acetaminophen
Drug: Acetaminophen IV Soln 10 MG/ML
Drug: Hydromorphone

First Posted Date: 2017-04-07

Last Posted Date: 2019-10-08

Lead Sponsor: University of Southern California

Target Recruit Count: 28

Registration Number: NCT03104816

Locations: 🇺🇸
Keck Hospital of USC, Los Angeles, California, United States

Endoscopic Stenting Across the Papilla Versus the Leak Site to Treat Bile Leak

Not Applicable

Conditions: Bile Leak

Interventions: Procedure: Transpapillary Stent
Procedure: Stent across bile leak

First Posted Date: 2017-04-06

Last Posted Date: 2023-09-21

Lead Sponsor: University of Southern California

Target Recruit Count: 92

Registration Number: NCT03103139

Locations: 🇺🇸
Los Angeles County Hospital, Los Angeles, California, United States

Reducing the Duration of Untreated Psychosis

Completed

Conditions: First Episode Psychosis

First Posted Date: 2017-04-05

Last Posted Date: 2023-01-11

Lead Sponsor: University of Southern California

Target Recruit Count: 137

Registration Number: NCT03102151

Locations: 🇺🇸
San Fernando Mental Health Center, Granada Hills, California, United States

Effects of e-Cigarettes on Nicotine Withdrawal

Not Applicable

Completed

Conditions: Electronic Cigarettes

Interventions: Other: e-Cigarette

First Posted Date: 2017-03-31

Last Posted Date: 2023-07-11

Lead Sponsor: University of Southern California

Target Recruit Count: 37

Registration Number: NCT03098004

Locations: 🇺🇸
USC Health, Emotion and Addiction Laboratory, Los Angeles, California, United States

Movement Tracking Devices to Monitor Physical Activity in Patients Undergoing Chemotherapy

Not Applicable

Active, not recruiting

Conditions: Solid Neoplasm

Interventions: Device: Accelerometer
Other: Laboratory Biomarker Analysis
Other: Physical Activity Measurement
Behavioral: Telephone-Based Intervention

First Posted Date: 2017-03-31

Last Posted Date: 2024-08-28

Lead Sponsor: University of Southern California

Target Recruit Count: 41

Registration Number: NCT03098277

Locations: 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸
USC Norris Oncology/Hematology-Newport Beach, Newport Beach, California, United States
🇺🇸
Los Angeles County-USC Medical Center, Los Angeles, California, United States

Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer

Phase 2

Active, not recruiting

Conditions: Recurrent Renal Cell Carcinoma
Stage IV Renal Cell Cancer
Clear Cell Renal Cell Carcinoma
Metastatic Renal Cell Cancer

Interventions: Biological: Anti-OX40 Antibody PF-04518600
Drug: Axitinib
Other: Laboratory Biomarker Analysis
Other: Placebo

First Posted Date: 2017-03-28

Last Posted Date: 2024-08-28

Lead Sponsor: University of Southern California

Target Recruit Count: 62

Registration Number: NCT03092856

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
🇺🇸
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States
🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

and more 7 locations

Oxandrolone Rotator Cuff Trial

Not Applicable

Active, not recruiting

Conditions: Rotator Cuff Tear

Interventions: Drug: Placebo
Drug: Oxandrolone

First Posted Date: 2017-03-27

Last Posted Date: 2024-12-12

Lead Sponsor: University of Southern California

Target Recruit Count: 116

Registration Number: NCT03091075

Locations: 🇺🇸
Keck School of Medicine of the University of Southern California, Los Angeles, California, United States

Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung Cancer

Completed

Conditions: Stage IB Non-Small Cell Lung Carcinoma
Stage IIA Non-Small Cell Lung Carcinoma
Stage IA Non-Small Cell Lung Carcinoma
Stage IIB Non-Small Cell Lung Carcinoma

Interventions: Device: Computed Tomography Perfusion Imaging
Other: Laboratory Biomarker Analysis
Radiation: Stereotactic Body Radiation Therapy

First Posted Date: 2017-03-27

Last Posted Date: 2024-07-11

Lead Sponsor: University of Southern California

Target Recruit Count: 15

Registration Number: NCT03091816

Locations: 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

QSM and Regional DCE MRI Permeability Using GOCART Technique

Withdrawn

Conditions: Intracranial Neoplasm

Interventions: Device: Dynamic Contrast-Enhanced Magnetic Resonance Imaging
Drug: Gadobenate Dimeglumine
Drug: Gadoterate Meglumine
Device: Magnetic Resonance Imaging

First Posted Date: 2017-03-27

Last Posted Date: 2021-04-05

Lead Sponsor: University of Southern California

Registration Number: NCT03091803

Locations: 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy